Jeffrey Friedland serves as Executive at Intiva BioPharma Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey Friedland has executed 12 insider transactions totaling $450.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 22, 2019 involved gifting 228,800 shares valued at $0.
Jeffrey Friedland currently holds 19,000,000 shares of Intiva BioPharma Inc. (KDRH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Friedland has been a net seller of KDRH stock. They have purchased $0 and sold $450.0K worth of shares.
Jeffrey Friedland's most recent insider trade was on Nov 22, 2019, when they sold 228,800 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 4, 2019 | NXEN | $450.0K | Sale | 5,000,000 | $0.09 | Discretionary |
| Mar 8, 2018 | NTVA | $0 | Disposition | 1,166,667 | $N/A | Discretionary |
| Jan 16, 2018 | NTVA | $5.2K | Small Acquisition | 20,800 | $0.25 | Discretionary |
| Nov 29, 2017 | KDRH | $0 | Other | 15,099,083 | $N/A | Discretionary |
| Nov 29, 2017 | KDRH | $0 | Other | 1,258,257 | $N/A | Discretionary |
| Nov 29, 2017 | KDRH | $0 | Other | 130,859 | $N/A | Discretionary |
| Oct 13, 2017 | KDRH | $0 | Other | 20,000,000 | $N/A | Discretionary |
| Oct 13, 2017 | KDRH | $0 | Other | 462,848 | $N/A | Discretionary |
| Oct 13, 2017 | KDRH | $0 | Other | 4,450,458 | $N/A | Discretionary |
| Oct 13, 2017 | KDRH | $0 | Other | 53,405,501 | $N/A | Discretionary |